CJ-13610
Chemical Name: 4-[3-Fluoro-5-[4-(2-methyl-1H-imidazol-1-yl)phenylsulfanyl]phenyl]tetrahydro-2H-pyran-4-carboxamide hydrochloride
CAS No. 179420-35-0
项目整合开发状态: Preclinical
项目研究机构: Pfizer (Originator)
合成路线:Alkylation of 3,5-difluorophenylacetonitrile (I) with bis-(2-chloroethyl)ether (II) affords the tetrahydropyran derivative (III).Subsequent displacement of one fluoride group of (III) with sodium methylsulfide in hot DMF yields thioether (IV).Oxidation of (IV) employing NaIO4 leads to sulfoxide (V).Then,Pummerer rearrangement of sulfoxide (V) with trifluoroacetic anhydride,followed by basic hydrolysis,furnishes thiol (VI)
合成路线:Arylation of 2-methylimidazole (VII) with1-fluoro-4-iodobenzene (VIII) gives the iodophenyl imidazole (IX).Then,condensation of aryl iodide (IX) with thiophenol (VI) produces the diaryl sulfide (X).Finally,partial hydrolysis of the cyano group of (X) employing KOH in t-butanol yields the target carboxamide
📌 参考资料/链接:
参考文献标题:5-Lipoxygenase inhibitors
文献作者:Stevens,R.W.; Mano,T.; Nakao,K.; Okumura,Y.(Pfizer Inc.)
参考来源:EP 0787127; JP 1999507322; US 5883106; WO 9611911